Your browser doesn't support javascript.
loading
Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.
Fangning, Wan; Chunguang, Ma; Hailiang, Zhang; Guohai, Shi; Yao, Zhu; Bo, Dai; Yijun, Shen; Yiping, Zhu; Dingwei, Ye.
Afiliação
  • Fangning W; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032 People's Republic of China.
  • Chunguang M; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China.
  • Hailiang Z; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032 People's Republic of China.
  • Guohai S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China.
  • Yao Z; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032 People's Republic of China.
  • Bo D; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China.
  • Yijun S; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032 People's Republic of China.
  • Yiping Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China.
  • Dingwei Y; Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032 People's Republic of China.
J Cancer ; 8(11): 2010-2017, 2017.
Article em En | MEDLINE | ID: mdl-28819401

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Ano de publicação: 2017 Tipo de documento: Article